Gensco Pharma

Executive Summary

Gensco Pharma is a specialty pharmaceutical company headquartered in San Diego, California, founded in 2015. The company focuses on the research, development, and commercialization of transdermal and topical prescription products, leveraging its proprietary MDose® metered-dose applicator and transdermal delivery systems. Gensco's product pipeline centers on non-narcotic analgesic gels and other treatments, addressing the growing demand for non-opioid pain management alternatives. With an 'Approved' stage status, the company has at least one commercial product and continues to expand its portfolio through internal development and potential partnerships. Gensco's differentiated drug delivery platform offers improved patient compliance and dosing accuracy, positioning it as a niche player in the drug delivery market.

Upcoming Catalysts (preview)

• Q1 2027FDA approval of new transdermal analgesic product70% success
• Q3 2026Launch of MDose-based topical gel for chronic pain80% success
• Q4 2026Strategic partnership or licensing deal for drug delivery platform60% success